Fibroblast activation and myofibroblast generation in obstructive nephropathy
- PMID: 19474827
- DOI: 10.1038/nrneph.2009.74
Fibroblast activation and myofibroblast generation in obstructive nephropathy
Abstract
Obstructive nephropathy is a major cause of renal failure, particularly in newborn babies and children. After urinary tract obstruction, and under the influence of mechanical forces and cytokines produced by tubular cells and cells that have infiltrated the interstitium, resident fibroblasts undergo activation and myofibroblasts are generated from bone-marrow-derived cells, pericytes and endothelial cells. In addition, selected tubular epithelial cells can become fibroblast-like cells via epithelial-mesenchymal transition. This transition is characterized by downregulation of epithelial marker proteins such as E-cadherin, zonula occludens 1 and cytokeratin; loss of cell-to-cell adhesion; upregulation of mesenchymal markers including vimentin, alpha-smooth muscle actin and fibroblast-specific protein 1; basement membrane degradation; and migration to the interstitial compartment. All the events of epithelial-mesenchymal transition are strictly regulated by complex signaling pathways. Myofibroblasts and activated fibroblasts proliferate and produce large amounts of extracellular matrix, which accumulates in the tubular interstitium; together with tubular atrophy, this accumulation leads to interstitial fibrosis. This Review examines the molecular mechanisms of fibroblast activation and epithelial-mesenchymal transition, processes that seem to be promising targets for the prevention, or even reversal, of interstitial fibrosis and renal dysfunction associated with obstructive nephropathy.
Similar articles
-
Obstructive nephropathy: towards biomarker discovery and gene therapy.Nat Clin Pract Nephrol. 2006 Mar;2(3):157-68. doi: 10.1038/ncpneph0098. Nat Clin Pract Nephrol. 2006. PMID: 16932414 Review.
-
Obstructive uropathy.Contrib Nephrol. 2011;169:311-326. doi: 10.1159/000314578. Epub 2011 Jan 20. Contrib Nephrol. 2011. PMID: 21252529
-
Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition.FASEB J. 2021 Mar;35(3):e21381. doi: 10.1096/fj.202000926RR. FASEB J. 2021. PMID: 33617091
-
Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.Hum Pathol. 2009 Oct;40(10):1365-76. doi: 10.1016/j.humpath.2009.02.020. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695676 Review.
-
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.Kidney Int. 2010 Aug;78(3):257-68. doi: 10.1038/ki.2010.154. Epub 2010 Jun 2. Kidney Int. 2010. PMID: 20520592
Cited by
-
IL-18 deficiency ameliorates the progression from AKI to CKD.Cell Death Dis. 2022 Nov 15;13(11):957. doi: 10.1038/s41419-022-05394-4. Cell Death Dis. 2022. PMID: 36379914 Free PMC article.
-
TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions.Biochem Biophys Rep. 2019 Jan 8;17:139-150. doi: 10.1016/j.bbrep.2018.12.006. eCollection 2019 Mar. Biochem Biophys Rep. 2019. PMID: 30662960 Free PMC article.
-
Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition-An Outstanding Challenge.Front Pharmacol. 2019 Apr 18;10:388. doi: 10.3389/fphar.2019.00388. eCollection 2019. Front Pharmacol. 2019. PMID: 31057405 Free PMC article. Review.
-
Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis.PLoS One. 2014 Jul 23;9(7):e103240. doi: 10.1371/journal.pone.0103240. eCollection 2014. PLoS One. 2014. PMID: 25054240 Free PMC article.
-
The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.PLoS One. 2014 Sep 4;9(9):e106554. doi: 10.1371/journal.pone.0106554. eCollection 2014. PLoS One. 2014. PMID: 25188319 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials